Pharmaceutical involvement in phase II breast cancer clinical trials

被引：1
|
作者：
Schneider, A.
Zhang, T.
Kamal, A.
Patel, K.
Hamilton, E. P.
Peppercorn, J. M.
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.6104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6104
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The group sequential triangular test for phase II cancer clinical trials
    Bellissant, E
    Benichou, J
    Chastang, C
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (04): : 422 - 430
  • [32] Phase II cancer clinical trials for biomarker-guided treatments
    Jung, Sin-Ho
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (02) : 256 - 263
  • [33] Photosensitizer Radachlorin®: Skin cancer PDT phase II clinical trials
    Kochneva, Elena V.
    Filonenko, Elena V.
    Vakulovskaya, Elena G.
    Scherbakova, Elena G.
    Seliverstov, Oleg V.
    Markichev, Nikolay A.
    Reshetnickov, Andrei V.
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2010, 7 (04) : 258 - 267
  • [34] Clinical outcomes of patients with metastatic breast cancer enrolled in phase I clinical trials
    Criscitiello, Carmen
    Marra, Antonio
    Morganti, Stefania
    Zagami, Paola
    Gandini, Sara
    Esposito, Angela
    Curigliano, Giuseppe
    [J]. EUROPEAN JOURNAL OF CANCER, 2021, 157 : 40 - 49
  • [35] RANDOMIZED PHASE II CLINICAL TRIALS
    Jung, Sin-Ho
    Sargent, Daniel J.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2014, 24 (04) : 802 - 816
  • [36] Current phase II and phase III clinical trials for pancreatic cancer - Referral resource
    Mooney, MM
    Schoenfeldt, M
    [J]. ONCOLOGY-NEW YORK, 2004, 18 (08): : 1008 - +
  • [37] Nursing, morality, and emotions: Phase I and phase II clinical trials and patients with cancer
    Krishnasamy, M
    [J]. CANCER NURSING, 1999, 22 (04) : 251 - 259
  • [38] PHASE-II TRIALS WITH TOREMIFENE IN ADVANCED BREAST-CANCER - A REVIEW
    VALAVAARA, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1990, 16 : S31 - S35
  • [39] ELIGIBILITY OF EPIGALLOCATECHIN GALLATE (EGCG) FOR PHASE II BREAST CANCER CHEMOPREVENTION TRIALS
    Iatropoulos, G. F.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 61 - 62
  • [40] Clinical Trials and Breast Cancer Disparities
    Bea, Vivian Jolley
    Taiwo, Evelyn
    Balogun, Onyinye D.
    Newman, Lisa A.
    [J]. CURRENT BREAST CANCER REPORTS, 2021, 13 (03) : 186 - 196
12345